Asset Management One Co. Ltd. Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Asset Management One Co. Ltd. raised its position in Agilent Technologies, Inc. (NYSE:A) by 1.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 116,493 shares of the medical research company’s stock after buying an additional 1,284 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Agilent Technologies were worth $17,297,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in A. National Pension Service raised its stake in shares of Agilent Technologies by 10.8% during the third quarter. National Pension Service now owns 702,631 shares of the medical research company’s stock worth $104,327,000 after purchasing an additional 68,670 shares during the last quarter. Opes Wealth Management LLC purchased a new stake in shares of Agilent Technologies during the third quarter worth approximately $202,000. Van ECK Associates Corp raised its stake in shares of Agilent Technologies by 6.6% during the third quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock worth $442,011,000 after purchasing an additional 183,716 shares during the last quarter. Janney Montgomery Scott LLC raised its stake in shares of Agilent Technologies by 1.5% during the third quarter. Janney Montgomery Scott LLC now owns 135,581 shares of the medical research company’s stock worth $20,131,000 after purchasing an additional 2,049 shares during the last quarter. Finally, Lmcg Investments LLC raised its stake in shares of Agilent Technologies by 1.4% during the third quarter. Lmcg Investments LLC now owns 80,231 shares of the medical research company’s stock worth $11,913,000 after purchasing an additional 1,140 shares during the last quarter.

Agilent Technologies Stock Performance

NYSE A opened at $140.41 on Wednesday. The business’s 50-day moving average price is $139.70 and its 200 day moving average price is $138.18. Agilent Technologies, Inc. has a twelve month low of $104.09 and a twelve month high of $155.35. The company has a market capitalization of $40.34 billion, a PE ratio of 29.13, a price-to-earnings-growth ratio of 6.02 and a beta of 1.07. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the prior year, the business posted $1.43 earnings per share. The firm’s revenue for the quarter was down 5.6% compared to the same quarter last year. On average, research analysts predict that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were issued a $0.236 dividend. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.67%. Agilent Technologies’s dividend payout ratio (DPR) is 19.50%.

Insider Transactions at Agilent Technologies

In other news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,995 shares of company stock worth $1,739,510 in the last three months.

Analyst Ratings Changes

Several equities research analysts have recently commented on A shares. Bank of America upped their price target on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Wells Fargo & Company started coverage on Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price objective on the stock. Citigroup upped their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Evercore ISI upped their price objective on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Finally, TD Cowen upped their price objective on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $144.36.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.